- Home
- / Atrium Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Atrium Health financials data including stock price, CreditSafe score, income statement, and acquistions and subsidiaries.
Revenue
$11.3 B
FY, 2020
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 10.3B | 10.7B | 11.3B |
| Revenue growth, % | 3.9% | 3.3% | |
| Cost of goods sold | 3.7B | 3.8B | |
| Gross profit | 6.6B | 6.8B | |
| Gross profit margin, % | 64.2% | 64.0% | |
| General and administrative expense | 5.6B | 5.8B | 6.4B |
| Operating expense total | 6.2B | 6.4B | 11.2B |
| Depreciation and amortization | 586.2M | 569.5M | 517.5M |
| Interest expense | 125.3M | 117.4M | |
| Net Income | (29.1M) | 1.3B | 1.0B |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |